FXCM News $FXCM FXCM January Metrics And PR: Long On

New Post Public Reply Private Reply Replies (0) Message Board

Feb 13, 2015 at 10:41 PM

FXCM News $FXCM

FXCM January Metrics And PR: Long On Porcine Lipstick, Short On Self-Awareness
Lenny Grover - at Seeking Alpha - Thu Feb 12, 1:02PM CST

FXCM: 2.21 (-0.01)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:36PM CST

COUP: 11.06 (-0.07), CJES: 12.98 (+1.36), BIDU: 212.13 (+7.11), FEYE: 42.26 (+2.63), CAKE: 48.22 (-1.04), GREK: 13.65 (+0.66), TRIP: 84.81 (+2.41), NTAP: 38.22 (+1.32), FXCM: 2.21 (-0.01), ZU: 14.22 (-0.30)

FXCM Reports Monthly Metrics
GlobeNewswire - Wed Feb 11, 3:07PM CST
FXCM Inc. (NYSE:FXCM) today announced certain key operating metrics for January 2015 for its retail and institutional foreign exchange business.
FXCM: 2.21 (-0.01)

Updates on Asset Investment Banking and Brokerage Stocks - FXCM Inc., TD Ameritrade Holding, RCS Capital, BGC Partners, and Nomura Holdings
PR Newswire - Tue Feb 10, 7:55AM CST
Editor Note: For more information about this release, please scroll to bottom.
RCAP: 10.28 (+0.28), NMR: 5.66 (+0.11), FXCM: 2.21 (-0.01), AMTD: 35.84 (-0.22), BGCP: 9.34 (+0.19)

Peeling The Onion Of FXCM's Misleading Marketing
Lenny Grover - at Seeking Alpha - Mon Feb 09, 7:07AM CST

FXCM: 2.21 (-0.01)

FXCM Upgrades Trading Station Platform
GlobeNewswire - Mon Feb 09, 7:06AM CST
FXCM Inc. (NYSE:FXCM), a leading online provider of forex trading and related services, announced today the launch of its comprehensive suite of Real Volume indicators exclusively for its flagship Trading Station platform. The volume indicators provide traders critical market data directly on the charts, the ability to analyze market behavior, and trading psychology by displaying what the crowd is doing.
FXCM: 2.21 (-0.01)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 8:12AM CST

SD: 2.09 (+0.14), FTR: 8.38 (+0.01), GRA: 101.61 (+1.69), PRU: 80.33 (+1.63), EOPN: 8.55 (-0.01), GMCR: 118.53 (+0.56), HPJ: 5.71 (+0.16), KORS: 73.27 (+1.72), NBG: 1.61 (+0.18), FXCM: 2.21 (-0.01), GLUU: 5.12 (+0.14), HSP: 87.35 (unch), GENE: 8.04 (+1.90), QUIK: 2.17 (+0.01), CONN: 24.69 (-0.07), PRCP: 10.94 (-0.04), TDC: 45.73 (-0.29), IRBT: 31.16 (+0.18), DATA: 99.90 (+1.40), SMRT: 15.82 (+0.11)

Misleading Marketing, Poor Risk Management, And Bad Trade Recommendations Dog FXCM
Lenny Grover - at Seeking Alpha - Mon Feb 02, 7:54AM CST

FXCM: 2.21 (-0.01)

Free Insider Trading Reports for Huntington Bancshares, FXCM, MasterCard, Procter & Gamble, Apple, and Kinder Morgan
PR Newswire - Mon Feb 02, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Huntington Bancshares (NASDAQ:HBAN), FXCM (NYSE:FXCM), MasterCard (NYSE:MA), Procter & Gamble (NYSE

G), Apple (NASDAQ:AAPL), and Kinder Morgan (NYSE:KMI).
KMI: 41.97 (+0.21), HBAN: 10.69 (-0.02), PG: 85.90 (-0.13), FXCM: 2.21 (-0.01), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38)

InsiderInsights.com Daily Round Up 1/30/15: FXCM, RYAM, CAS, SNCR
InsiderInsights - at Seeking Alpha - Sat Jan 31, 7:48AM CST

EA: 56.39 (+0.20), IMMR: 9.01 (-0.09), RYAM: 17.58 (+0.36), HBHC: 29.74 (-0.29), MIK: 27.45 (-0.35), FXCM: 2.21 (-0.01), WAFD: 21.13 (+0.07), SNCR: 43.89 (+1.06), ALB: 54.59 (+0.63), LGF: 32.17 (+0.08), TXN: 57.97 (+0.53), CUDA: 35.68 (-1.14), CAS: 6.14 (-0.01), INGN: 33.53 (+2.32), TRMK: 23.39 (+0.24), MSFT: 43.87 (+0.78), PB: 52.86 (+0.25), WIA: 11.49 (-0.03)

FXCM's 'Poison Pill' Is Just Another Empty News Release
Edward Vranic, CFA - at Seeking Alpha - Fri Jan 30, 1:09PM CST

FXCM: 2.21 (-0.01)

FXCM Adopts Stockholder Rights Plan
GlobeNewswire - Fri Jan 30, 5:59AM CST
FXCM Inc. (NYSE:FXCM), a leading online provider of foreign exchange, or FX, trading and related services, today announced that its Board of Directors has adopted a Stockholder Rights Plan (the "Rights Plan"

and declared a dividend distribution of one right on each outstanding share of the Company's Class A common stock.
FXCM: 2.21 (-0.01)

FXCM Spin Game Doesn't Change Its Misleading Marketing And Disclosures
Lenny Grover - at Seeking Alpha - Thu Jan 29, 7:10AM CST

FXCM: 2.21 (-0.01)

FXCM Forgiving Most Clients With Swiss Franc Losses
at Investor's Business Daily - Wed Jan 28, 11:23AM CST
FXCM (FXCM) said it will forgive about 90% of its clients who were hit with negative balances this month after the surprise surge in the Swiss franc battered their accounts. The retail foreign exchange broker will notify eligible clients and adjust...
LUK: 23.50 (-0.01), FXCM: 2.21 (-0.01)

FXCM Stock Jumping Today After Forgiving Clients' Negative Balances
at The Street - Wed Jan 28, 9:19AM CST
FXCM (FXCM) stock is sharply up this morning, following the company's announcement to forgive approximately 90% of its clients who incurred negative balances.
FXCM: 2.21 (-0.01)

FXCM forgiving most customers, but not most of the money
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 8:16AM CST

FXCM: 2.21 (-0.01)

FXCM to Forgive Majority of Clients Who Incurred Negative Balances
GlobeNewswire - Wed Jan 28, 7:57AM CST
FXCM Inc. (NYSE:FXCM), announced today its decision to forgive approximately 90% of its clients who incurred negative balances in certain jurisdictions, on January 15, 2014 as a result of the Swiss National Bank announcement on that date. FXCM will notify the applicable clients and adjust applicable client account statements in the next 24-48 hours.
FXCM: 2.21 (-0.01)

InsiderInsights.com Daily Round Up 1/26/15: THRM, FXCM, OPK, TCBI
InsiderInsights - at Seeking Alpha - Wed Jan 28, 3:00AM CST

AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), BALT: 1.74 (+0.09), EGBN: 36.43 (-0.31), FXCM: 2.21 (-0.01), TCBI: 48.51 (+0.81), THRM: 41.21 (+0.38), VEEV: 30.12 (+0.17), VSAR: 18.04 (-0.55), PN: 13.35 (-0.14), LNKD: 269.00 (+1.83), OPK: 13.80 (-0.28), NERV: 4.68 (+0.09), CAS: 6.14 (-0.01), SGNT: 27.75 (-0.41), ARIA: 7.35 (+0.45), TWTR: 48.50 (+0.55), BKE: 49.59 (-0.16)

Global Brokerage, Inc. (GLBR) Stock Research Links

GLBR Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...